Full name
HIGOSENSE SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
72.10.Z - Scientific research and development in natural and technical sciences
32.50.B - Other production of medical devices, instruments, and products
62.10.B - Programming activities
62.20.B - IT consulting and IT equipment management activities
71.20.C - Other technical testing and analysis
74.12.Z - Graphic design and visual communication activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -5,1 | -15,2 | -14,4 | 5,2 |
EBITDA | -4,5 | -13,5 | -10,9 | 19,5 |
Short time liabilities | 4,4 | 11,1 | 6,5 | -41,4 |
Equity capital | 19,8 | 4,6 | -9,8 | -310,7 |
Operating profit (EBIT) | -4,6 | -14,9 | -14,5 | 3,1 |
Assets | 39,4 | 22,6 | 21,6 | -4,3 |
Net profit (loss) | -5,1 | -15,2 | -14,4 | 5,2 |
Cash | 2,4 | 2,8 | 5,2 | 85,9 |
Net income from sale | 0,7 | 2,5 | 3,1 | 21,6 |
Liabilities and provisions for liabilities | 19,6 | 18 | 31,4 | 74,7 |
Working assets | 25,4 | 12,9 | 14,6 | 13,6 |
Depreciation | 0,1 | 1,4 | 3,6 | 153 |
% | % | % | p.p. | |
Profitability of capital | -25,8 | -327,6 | 147,5 | 475,1 |
Equity capital to total assets | 50,2 | 20,5 | -45,1 | -65,6 |
Gross profit margin | -729,9 | -602,9 | -470,4 | 132,5 |
EBITDA Margin | -648,7 | -536,7 | -355,5 | 181,2 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 2311 | 1606 | 774 | -832 |
Current financial liquidity indicator | 3.0217838287353516 | 0.7983670830726624 | 1.511651635169983 | 0,7 |
Net dept to EBITDA | -2.619394302368164 | -0.5564066171646118 | -1.935246467590332 | -1,3 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane